Codiak Biosciences Is A Clinical Stage Biopharmaceutical Company Based In Cambridgemassachusettsfounded In 2015The Company Specializes In Exosome Therapeuticsfocusing On The Use Of Exosomes For Targeted Drug Delivery And Advanced Diagnosticsexosomes Are Natural Vesicles That Facilitate Communication Between Cellsmaking Them A Promising Tool For Therapeutic Applications Codiak Is Actively Developing Exosome Based Therapeuticswith Two Programs Currently In Phase I Clinical Trialsthese Programs Highlight The Versatility Of Exosome Technology In Delivering Targeted Payloadsthe Company Has Also Established A Strong Intellectual Property Portfolioholding 18 Patents And Publishing 19 Research Papers Related To Exosome Biology
